Qiagen (QGEN) shares jumped 4% and were halted for volatility after Bloomberg’s Eyk Henning, Dinesh Nair, David Carnevali and Michelle Davis reported that the European molecular testing company is weighing strategic options, including a potential sale, as it has received renewed takeover interest. People with knowledge of the matter said the company is working with advisers as its supervisory board fields preliminary interest from potential suitors, adding that Qiagen has held talks with several possible buyers in recent weeks, the report indicated.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QGEN:
- Qiagen trading halted, volatility trading pause
- Qiagen studying possible sale, Bloomberg says
- Goldman Sachs Discloses 3.6% Voting Stake in Qiagen
- Qiagen Reports AFM Notification of Major Stake by Massachusetts Financial Services
- Massachusetts Financial Services Discloses Nearly 10% Voting Stake in Qiagen